US Stock MarketDetailed Quotes
FBLG FibroBiologics
- 2.560
- +0.090+3.64%
Close Nov 27 16:00 ET
- 2.560
- 0.0000.00%
Post 20:01 ET
88.73MMarket Cap-4885P/E (TTM)
2.690High2.460Low108.50KVolume2.460Open2.470Pre Close274.24KTurnover0.43%Turnover RatioLossP/E (Static)34.66MShares55.00052wk High32.41P/B64.81MFloat Cap1.07852wk Low--Dividend TTM25.32MShs Float55.000Historical High--Div YieldTTM9.31%Amplitude1.078Historical Low2.527Avg Price1Lot Size
About FibroBiologics Company
FibroBiologics, Inc. engages in the development and commercialization of cell therapies. It focuses on treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The firm’s product pipeline includes CybroCell, CYMS101, CYWC628, TCB190, and CYTER915. The company was founded by Peter O’Heeron on April 8, 2021 and is headquartered in Houston, TX.
Company Profile
SymbolFBLG
Company NameFibroBiologics
Listing DateJan 31, 2024
Founded2021
CEOMr. Peter O’Heeron
MarketNASDAQ
Employees10
Fiscal Year Ends12-31
Address455 East Medical Center Boulevard,Suite 300
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77598
Phone1-281-671-5150
Company Executives
- Name
- Position
- Salary
- Peter O’Heeron
- Chairperson of the Board and Chief Executive Officer
- 4.29M
- Robert E. Hoffman, C.P.A.
- Director, Interim Chief Financial Officer and Principal Accounting Officer
- 388.54K
- Dr. Hamid Khoja, PhD
- Chief Scientific Officer
- 1.31M
- Matthew Link
- Independent Director
- 379.54K
- Stacy Ann Coen, M.B.A.
- Independent Director
- 384.54K
- Richard C. Cilento, Jr,M.B.A.
- Independent Director
- 376.54K
- Dr. Victoria Niklas, M.D.
- Independent Director
- 381.54K
- Ruben A. Garcia
- General Counsel
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data